The nation of Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) spanning five years because of Washington's demand for sensitive information.
This rejection came to light after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesperson later explained that the United States was seeking genetic material for research and commercial purposes while was unwilling to share the benefits from future medical innovations.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further negotiations to find a agreement agreeable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Implications
This development follows a similar case in neighbouring Kenya, where a high court blocked a related health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had overseen aid for the American government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral deals to enhance transparency and responsibility.
Based on reports, 16 African countries have to date signed these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," his statement read.
"In essence, our country would supply the basic resources for medical research without any certainty that the resulting innovations would be available to our population should a new pandemic emerge."
Sovereignty and Global Health
Mangwana further said that the American exit from the global health body and its pursuit of bilateral deals were disrupting frameworks already set up through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.
"This framework is designed to ensure that when a country provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage ongoing discussions with our US partners on how subsequent co-operation might be structured in a way that honours the sovereignty and dignity of each country."
Health Experts Reaction
A leading public health body expressed it acknowledged the official position, but recommended that talks should continue given that much of the country's Aids initiatives were funded by foreign aid.
"Where technical issues arise, including those involving data governance or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," it added.
The situation underscores the continuing challenges between accepting vital foreign assistance and safeguarding local interests in an increasingly data-driven world.